Previous Article | Next Article ![]()
J. Bacteriol., Jun 1995, 3227-3234, Vol 177, No. 11
M el-Sherbeini and JA Clemas
The GNS1 gene product is required for the synthesis of 1,3-beta-glucan in
vitro, since mutations in this gene result in exhibit an 80 to 90%
reduction in 1,3-beta-glucan synthase specific activity. gns1 mutant
strains display a pleiotropic phenotype including resistance to a
pneumocandin B0 analog (L-733,560), slow growth, and mating and sporulation
defects. The gns1-1 mutation was genetically mapped to within 1.35
centimorgans from the MAT locus on chromosome III. The wild- type GNS1 gene
was isolated by complementing the pneumocandin resistance phenotype of the
gns1-1 mutation and by hybridization with a chromosome III-derived sequence
being used as a probe. The nucleotide sequence of GNS1 was determined and
compared with the homologous region of the chromosome. The genetic and
nucleotide sequence analyzes revealed that GNS1 and the open reading frame,
YCR34 [S. Oliver, Q. van der Aart, M. Agostoni-Carbone, and the Chromosome
III Sequencing Group, Nature (London) 357:38-46, 1992], represent identical
loci in the genome. Cells deleted for GNS1 are viable but exhibit slow
growth as well as the pleiotropic phenotype of the gns1 mutants. The
putative protein product is predicted to be an integral membrane protein
with five transmembrane helices displaying an exoplasmic orientation for
the N terminus and a cytoplasmic orientation for the C terminus. This
protein may be a subunit of 1,3-beta-glucan synthase.
Copyright © 1995, American Society for Microbiology
Cloning and characterization of GNS1: a Saccharomyces cerevisiae gene involved in synthesis of 1,3-beta-glucan in vitro
Merck Research Laboratories, Rahway, New Jersey 07065, USA.
This article has been cited by other articles:
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |